No quantitative relationship between CR1 and Lutheran expression on erythrocytes: In(Lu) gene product is not a common regulator of CR1 expression on erythrocytes

Experimental and Clinical Immunogenetics

Volumn 16, Issue 2, 1999, Pages 72-80

  Oudin, S ^a   Lepennec, P Y ^c   Dervillez, X ^a   Tonye Libyh, M ^a   Tabary, T ^a   Philbert, F ^a   Bougy, F ^a   Reveil, B ^a   Pennaforte, J L ^b   Rouger, P ^c   Cohen, J H M ^a,b  

^a Pole Biomolecules IFR 53   (France)

^b REIMS UNIVERSITY HOSPITAL   (France)

^c INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

Erythrocytes; Gene expression regulation; Lupus erythematosus, systemic; Lutheran blood group; Receptors, complement 3b

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C4B; GENE PRODUCT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BLOOD GROUP LUTHERAN SYSTEM; CHROMOSOME; CONTROLLED STUDY; ERYTHROCYTE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENOTYPE; HEMOLYTIC ANEMIA; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR DENSITY; REGULATOR GENE; RETICULOCYTE; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSCRIPTION REGULATION;

ANTIBODIES, MONOCLONAL; BLOOD GROUPING AND CROSSMATCHING; ERYTHROCYTES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUTHERAN BLOOD-GROUP SYSTEM; RECEPTORS, COMPLEMENT 3B; STAINING AND LABELING;

EID: 0032965127     PISSN: 02549670     EISSN: None     Source Type: Journal    
DOI: 10.1159/000019098     Document Type: Article

References (37)

1. Rodriguez de Cordoba S, Rubinstein P: Quantitative variations of the C3b/C4b receptor (CR1) in human erythrocytes are controlled by genes within the regulator of complement activation (RCA) gene cluster. J Exp Med 1986;164:1274-1283.
2. Wilson JG, Murphy EE, Wong WW, Klickstein LB, Weis JH, Fearon DT: Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes. J Exp Med 1986;164:50-59.
3. Wong WW, Klickstein LB, Smith JA, Weis JH, Fearon DR: Identification of a partial cDNA clone for the human receptor for complement fragments C3b/C4b. Proc Natl Acad Sci USA 1985;82:7711-7715.
4. Cornillet P, Philbert F, Kazatchkine MD, Cohen JH: Genomic determination of the CR1 (CD35) density polymorphism on erythrocytes using polymerase chain reaction amplification and HindIII restriction enzyme digestion. J Immunol Methods 1991;136:193-197.
5. Moulds JM, Brai M, Cohen J, Cortelazzo A, Cuccia M, Lin M, Sadallah S, Schifferli J, Bala Subramanian V, Truedsson L, Wu GW, Zhang F, Atkinson JP: Reference typing report for complement receptor 1 (CR1). Exp Clin Immunogenet 1998;15: 291-294.
6. Moldenhauer F, Botto M, Walport MJ: The rate of loss of CR1 from ageing erythrocytes in vivo in normal subjects and SLE patients: No correlation with structural or numerical polymorphisms. Clin Exp Immunol 1988;72:74-78.
7. Ripoche J, Sim RB: Loss of complement receptor type 1 (CR1) on ageing of erythrocytes. Studies of proteolytic release of the receptor. Biochem J 1986;235:815-821.
8. Cohen JH, Lutz HU, Pennaforte JL, Bouchard A, Kazatchkine MD: Peripheral catabolism of CR1 (the C3b receptor, CD35) on erythrocytes from healthy individuals and patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1992;87:422-428.
9. Cohen JH, Caudwell V, Levi-Strauss M, Bourgeois P, Kazatchkine MD: Genetic analysis of CR1 expression on erythrocytes of patients with systemic lupus erythematosus. Arthritis Rheum 1989;32: 393-397.
10. Miyakawa Y, Yamada A, Kosaka K, Tsuda F, Kosugi E, Mayumi M: Defective immune-adherence (C3b) receptor on erythrocytes from patients with systemic lupus erythematosus. Lancet 1981;ii:493-497.
11. Wilson JG, Fearon DT: Altered expression of complement receptors as a pathogenic factor in systemic lupus erythematosus. Arthritis Rheum 1984;27:1321-1328.
12. Cohen JH, Geffriaud C, Caudwell V, Kazatchkine MD: Genetic analysis of CR1 (the C3b complement receptor, CD35) expression on erythrocytes of HIV-infected individuals. AIDS 1989;3:397-399.
13. Tausk FA, McCutchan A, Spechko P, Schreiber RD, Gigly I: Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome. J Clin Invest 1986;78:977-982.
14. Walport M, Ng YC, Lachmann PJ: Erythrocytes transfused into patients with SLE and haemolytic anaemia lose complement receptor type 1 from their cell surface. Clin Exp Immunol 1987;69:501-507.
15. Barbosa JE, Harrison RA, Barker PJ, Lachmann PJ: An anti-peptide antibody that recognizes a neo-antigen in the CR1 stump remaining on erythrocytes after proteolysis. Clin Exp Immunol 1992;87:144-149.
16. Danielsson C, Pascual M, French L, Steiger G, Schifferli JA: Soluble complement receptor type 1 (CD35) is released from leukocytes by surface cleavage. Eur J Immunol 1994; 24:2725-2731.
17. Pascual M, Lutz HU, Steiger G, Stammler P, Schifferli JA: Release of vesicles enriched in complement receptor 1 from human erythrocytes. J Immunol 1993;151:397-404.
18. Dervillez X, Oudin S, Libyh MT, Tabary T, Reveil B, Philbert F, Bougy F, Pluot M, Cohen JH: Catabolism of the human erythrocyte C3b/ C4b receptor (CR1. CD35): vesiculation and/or proteolysis? Immunopharmacology 1997;38:129-140.
19. Daniels GL, Shaw MA, Lomas CG, Leak MR, Tippett P: The effect of In(Lu) on some high-frequency antigens. Transfusion 1986;26:171-172.
20. Moulds JM, Rowe KE: Neutralization of Knops system antibodies using soluble complement receptor 1. Transfusion 1996;36:517-520.
21. Moulds JM, Nickells MW, Moulds JJ, Brown MC, Atkinson JP: The C3b/C4b receptor is recognized by the Knops, McGoy, Swain-Langley, and York blood group antisera. J Exp Med 1991;173:1159-1163.
22. Gibson T: Two kindreds with the rare dominant inhibitor of the lutheran and p1 red cell antigens. Hum Hered 1976;26:171-174.
23. Marsh WL, Brown PJ, DiNapoli J, Beck ML, Wood M, Wojcicki R, de la Camara C: Anti-Wj: An autoantibody that defines a high-incidence antigen modified by the In(Lu) gene. Transfusion 1983;23:128-130.
24. Rao N, Telen MJ: Lutheran antigens, lutheran regulatory genes, and lutheran regulatory gene targets; in Cartron JP, Rouger P (ed): Molecular basis of human blood group antigens. Blood cell biochemistry. New York, Plenum Press, 1994, vol 6, pp 281-297.
25. El Nemer W, Rahuel C, Colin Y, Gane P, Cartron JP, Le Van Kim C: Organization of the human LU gene and molecular basis of the Lu(a)/ Lu(b) blood group polymorphism. Blood 1997;89:4608-4616.
26. Guy K, Green C: The influence of the In(Lu) gene on expression of CDw75 antigens on human red blood cells. Immunology 1992;75: 713-716.
27. Norman PC, Tippett P, Beal RW: An Lu(a-b-) phenotype caused by an X-linked recessive gene. Vox Sang 1986;51:49-52.
28. Hochberg MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus (letter) (see comments). Comments. Comment in: Arthritis Rheum 1998;41:751. Arthritis Rheum 1997;40:1725.
29. Hochberg MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus (letter) (see comments). Comments. Comment in: Arthritis Rheum 1998;41:751. Arthritis Rheum 1997;40:1725.
30. Parsons SF, Mallison G, Judson PA, Anstee DJ. Tanner MJ, Daniels GL: Evidence that the Lub blood group antigen is located on red cell membrane glycoproteins of 85 and 78 kD. Transfusion 1987;27:61-63.
31. Salmon CH, Cartron JP, Rouger P: Les groupes sanguins chez l'homme. Paris, Masson, 1991.
32. Cohen JH, Aubry JP, Jouvin MH, Wijdenes J, Bancherau J, Kazatchkine M, Revillard JP: Enumeration of CR1 complement receptors on erythrocytes using a new method for detecting low-density cell surface antigens by flow cytometry. J Immunol Methods 1987;99:53-58.
33. Cornillet P, Philbert F, Kazatchkine MD, Cohen JH: Genomic determination of the CR1 (CD35) density polymorphism on erythrocytes using polymerase chain reaction amplification and HindIII restriction enzyme digestion. J Immunol Methods 1991;136:193-197.
34. Cornacoff JB, Hebert LA, Smead WL, Van Aman ME, Birmingham DJ, Waxman FJ: Primate erythrocyte-immune complex-clearing mechanism. J Clin Invest 1983; 71:236-247.
35. Medof ME, Iida K, Mold C, Nussenzweig V: Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes. J Exp Med 1982; 156:1739-1754.
36. Chevalier J, Kazatchkine MD: Distribution in clusters of complement receptor type one (CR1) on human erythrocytes. J Immunol 1989;142: 2031-2036.
37. Herrera AH, Xiang L, Martin SG, Lewis J, Wilson JG: Analysis of complement receptor type 1 (CR1) expression on erythrocytes and of CR1 allelic markers in Caucasian and African American populations. Clin Immunol Immunopathol 1998; 87:176-183.